QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
How does regional data from the Nordic countries add value?
Nordic registers have been described as a goldmine for producing Real-World Evidence (RWE) in health and welfare research.
The benefits of national registers are well-known; these administrative registers provide comprehensive longitudinal individual-level data with complete coverage for the total population.
Today, we’d like to give special attention to the regional data available in the Nordics, which may be utilized either as a complement or standalone data source.
Regional data provides health care-related […]
Welcome Vegard!
Meet our new colleague Vegard Lybæk who joined our Stockholm office this week!
Following his completion of a master’s degree in economics from Uppsala universitet, Vegard is joining the Real World Evidence and Analytics unit as Research Analyst.
“𝘐 𝘢𝘮 𝘵𝘩𝘳𝘪𝘭𝘭𝘦𝘥 𝘵𝘰 𝘫𝘰𝘪𝘯 𝘵𝘩𝘦 𝘘𝘶𝘢𝘯𝘵𝘪𝘧𝘺 𝘵𝘦𝘢𝘮 𝘢𝘯𝘥 𝘵𝘰 𝘣𝘦 𝘢 𝘱𝘢𝘳𝘵 𝘰𝘧 𝘵𝘩𝘪𝘴 𝘤𝘰𝘮𝘱𝘢𝘯𝘺’𝘴 𝘫𝘰𝘶𝘳𝘯𝘦𝘺. 𝘐 𝘭𝘰𝘰𝘬 𝘧𝘰𝘳𝘸𝘢𝘳𝘥 𝘵𝘰 𝘤𝘰𝘯𝘵𝘳𝘪𝘣𝘶𝘵𝘪𝘯𝘨 𝘸𝘪𝘵𝘩 𝘮𝘺 𝘴𝘬𝘪𝘭𝘭𝘴 𝘵𝘰 𝘵𝘩𝘦 […]
Welcome Argyris!
This week we are welcoming Argyris Chlorogiannis as a Research Analyst to our Modelling, Access, and Strategy team in Stockholm.
Argyris is a Pharmacist with a Master’s degree in Health Economics, Policy, and Management from Karolinska Institutet. Before joining Quantify Research, Argyris gained valuable experience in modelling through his Master’s thesis, where he developed and adapted a cost-effectiveness […]
The ISPOR Value Flower: Blooming or withering in today´s healthcare landscape?
In an era where healthcare decisions are becoming increasingly complex, the ISPOR Value Flower offers a refreshing perspective on how we assess the true value of medical interventions.
What is it?
The Value Flower is a conceptual model that expands beyond traditional cost-effectiveness analyses. Its “petals” represent various dimensions of value, most of which are not taken into account in traditional decision making.
Why is it more relevant than ever?
1. Holistic View: […]